J. Latvala et al., Assays for acetaldehyde-derived adducts in blood proteins based on antibodies against acetaldehyde/lipoprotein condensates, ALC CLIN EX, 25(11), 2001, pp. 1648-1653
Background: Acetaldehyde-derived protein condensates (adducts) have been su
ggested as promising biological markers of alcohol abuse because they repre
sent actual metabolites of ethanol. However, the detection of such condensa
tes in vivo has been hampered by a lack of sensitive and specific methods.
Methods: To develop new approaches for the detection of acetaldehyde adduct
s, we have raised antibodies against condensates with acetaldehyde and lipo
proteins, which have previously been shown to be readily modified by acetal
dehyde in vitro. The characteristics of these antibodies were compared with
those raised against bovine serum albumin/acetaldehyde adduct and against
other types of lipoprotein modifications, as induced by malondialdehyde, ox
idation, and acetylation.
Results: The antibodies raised against low-density lipoprotein (LDL)/acetal
dehyde, very low density lipoprotein (VLDL)/acetaldehyde, and bovine serum
albumin/acetaldehyde all reacted with protein adducts generated at physiolo
gically relevant concentrations of acetaldehyde in vitro, whereas the antib
odies raised against malondialdehyde/LDL, oxidized LDL, or acetylated LDL w
ere not found to cross-react with the acetaldehyde-derived adducts. In assa
ys for acetaldehyde adducts from erythrocyte and serum proteins of patients
with excessive ethanol consumption (n = 32) and healthy control individual
s (n = 22), the antibody prepared against the acetaldehyde/VLDL condensate
was found to provide the most effective detection of acetaldehyde adducts i
n vivo.
Conclusions: Current data indicate that acetaldehyde generates immunogenic
adducts with lipoproteins in vivo. Antibodies raised against the VLDL/aceta
ldehyde may provide a basis for new diagnostic assays to examine excessive
alcohol consumption.